Hearing loss among patients on treatment for drug-resistant tuberculosis in Uganda
Introduction: Second-line injectable therapy using aminoglycosides (AG) like kanamycin, amikacin or capreomycin is associated with irreversible hearing loss. We aimed to determine the incidence and predictors of hearing loss among patients with drug resistant tuberculosis (DR-TB) who received AG. Me...
Saved in:
Main Authors: | Lodiong Jackson Dumo Lodiong (Author), Timbine Amos (Author), Boniface Amanee Elias Lumori (Author), Edwin Nuwagira (Author) |
---|---|
Format: | Book |
Published: |
Health and Social Sciences Research Institute - South Sudan (HSSRI-SS),
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical guidelines for managing hearing loss as a complication of drug-resistant tuberculosis treatment: an evaluation of implementation fidelity in Kano, Nigeria
by: Sani Ibrahim Muhammad, et al.
Published: (2022) -
South African adolescents' lived experiences of acquired hearing loss following multidrug-resistant tuberculosis treatment
by: Tarryn Sparg, et al.
Published: (2024) -
Trajectory of hearing loss in children with unilateral hearing loss
by: Elizabeth M. Fitzpatrick, et al.
Published: (2023) -
Endoscopically diagnosed hookworm infestation in an adult with chronic iron deficiency anaemia
by: Mohamed Mukhtar Abdirahman, et al.
Published: (2024) -
Hearing Loss
Published: (2012)